Search research articles
Contact Us
Filters
Showing results (11-20 of 57) with videos related to
Page
of 6
Sort By:
Journal of Gastrointestinal Cancer
|
March 11, 2014
Impact of preoperative and postoperative FOLFOX chemotherapies in patients with resectable colorectal liver metastasis
Matthieu Faron, Mircea Chirica, Hadrien Tranchard, et al.
Anticancer Research
|
July 9, 2011
Phase II trial of weekly alternating sequential BIBF 1120 and afatinib for advanced colorectal cancer
Olivier Bouche, Frederique Maindrault-Goebel, Michel Ducreux, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2024
Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients
Ofer Margalit, Amos Stemmer, William J Chapin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2006
Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer
Richard M Goldberg, Isabelle Tabah-Fisch, Harry Bleiberg, et al.
Journal of the National Cancer Institute
|
April 16, 2020
Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal Cancer
Kaysia Ludford, Romain Cohen, Magali Svrcek, et al.
Future Oncology (London, England)
|
December 26, 2024
MOUNTAINEER-03 phase III study design: first-line mFOLFOX6 + tucatinib + trastuzumab for HER2+ metastatic colorectal cancer
John H Strickler, Tanios Bekaii-Saab, Andrea Cercek, et al.
Annals of Surgical Oncology
|
July 7, 2018
Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study
Brice Malgras, Etienne Gayat, Olivier Aoun, et al.
Presse Medicale (Paris, France : 1983)
|
October 24, 2007
[PET and digestive cancers]
Jean-Noël Talbot, Françoise Montravers, Fabrice Gutman, et al.
Bulletin Du Cancer
|
January 9, 2021
[What should we remember from 2020?]
Jacques-Olivier Bay, Thierry Andre, Carole Bouleuc, et al.
BMC Cancer
|
July 9, 2016
Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program
Antoine Adenis, Christelle de la Fouchardiere, Bernard Paule, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 57) with videos related to
Sort By:
Page
of 6
Journal of Gastrointestinal Cancer
|
March 11, 2014
Impact of preoperative and postoperative FOLFOX chemotherapies in patients with resectable colorectal liver metastasis
Matthieu Faron, Mircea Chirica, Hadrien Tranchard, et al.
Anticancer Research
|
July 9, 2011
Phase II trial of weekly alternating sequential BIBF 1120 and afatinib for advanced colorectal cancer
Olivier Bouche, Frederique Maindrault-Goebel, Michel Ducreux, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2024
Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients
Ofer Margalit, Amos Stemmer, William J Chapin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2006
Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer
Richard M Goldberg, Isabelle Tabah-Fisch, Harry Bleiberg, et al.
Journal of the National Cancer Institute
|
April 16, 2020
Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal Cancer
Kaysia Ludford, Romain Cohen, Magali Svrcek, et al.
Future Oncology (London, England)
|
December 26, 2024
MOUNTAINEER-03 phase III study design: first-line mFOLFOX6 + tucatinib + trastuzumab for HER2+ metastatic colorectal cancer
John H Strickler, Tanios Bekaii-Saab, Andrea Cercek, et al.
Annals of Surgical Oncology
|
July 7, 2018
Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study
Brice Malgras, Etienne Gayat, Olivier Aoun, et al.
Presse Medicale (Paris, France : 1983)
|
October 24, 2007
[PET and digestive cancers]
Jean-Noël Talbot, Françoise Montravers, Fabrice Gutman, et al.
Bulletin Du Cancer
|
January 9, 2021
[What should we remember from 2020?]
Jacques-Olivier Bay, Thierry Andre, Carole Bouleuc, et al.
BMC Cancer
|
July 9, 2016
Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program
Antoine Adenis, Christelle de la Fouchardiere, Bernard Paule, et al.
Page
of 6